Form 4: BLFS CMO Sells Shares for Tax Obligations

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 354 shares of common stock to cover tax withholding obligations.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 354 shares of BLFS common stock.
• The sale occurred on August 26, 2025, at a price of $25.44 per share.
• This sale was executed under a Rule 10b5-1(c) trading plan, which was adopted on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.
• Following this transaction, Todd Berard beneficially owns 134,264 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, pre-planned sale by an executive to cover tax obligations associated with restricted stock vesting. It does not reflect a discretionary decision based on company performance or outlook, thus having a neutral impact on sentiment.

Positives

• The sale was pre-planned under a Rule 10b5-1(c) trading plan, indicating a structured approach to managing equity and tax obligations rather than a discretionary sale based on market timing.
• The transaction is for tax withholding, a routine event for executives with vesting equity, not a discretionary sale indicating a lack of confidence.

Negatives

• A reduction in direct beneficial ownership by an executive, even if for tax purposes, slightly decreases their direct equity alignment with shareholders.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Management Comments

• The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

This filing is specific to BioLife Solutions and its executive's personal stock management. It does not provide information relevant to broader industry trends or competitors. Such transactions are common across all industries for executives managing equity compensation.

Stakeholder Impact

• Shareholders: Minimal impact as it's a routine, pre-planned transaction for tax purposes, not indicative of a change in executive confidence or company fundamentals.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of shares by a Chief Marketing Officer to cover tax obligations related to restricted stock vesting. Such transactions are common and generally do not reflect a change in the executive's confidence in the company or its future prospects. Therefore, this specific filing does not provide new information that would warrant a change in an existing investment thesis for BioLife Solutions; a 'hold' recommendation is appropriate as it maintains the current position based on broader company fundamentals.

Keywords

BioLife Solutions, BLFS, Todd Berard, Chief Marketing Officer, CMO, SEC Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Tax Withholding, Restricted Stock